Naproxen Sodium (2 x 220 mg) Fasted Comparative Bioavailability Study
Status:
Completed
Trial end date:
2016-12-02
Target enrollment:
Participant gender:
Summary
This study is being conducted to investigate the rate and extent of naproxen absorption from
the Test naproxen sodium formulation is bioequivalent to Aleve® naproxen sodium, a Reference
product currently marketed in The Netherlands in order to support the registration of the
Reckitt Benckiser (RB) naproxen sodium (220 mg tablets).